Фармацевтические компании Германии
- TME Pharma. TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers.
- TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the...
- Yayın zamanı: dündünTME Pharma is a clinical-stage company focused on developing novel therapies for treatment of the most aggressive cancers.
- Yayın zamanı: dündünTME Pharma est une société au stade clinique spécialisée dans le développement de nouvelles thérapies pour le traitement des cancers les plus agressifs.
- TME Pharma's #Spiegelmer platform has generated a pipeline of cancer compounds targeting the tumor microenvironment (TME).
- TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact.
- Yayın zamanı: dündünThe presence of CCL2, the target chemokine of NOX-E36, has been shown to predict early surgical failure in glaucoma patients, TME Pharma highlights.
- TME Pharma NV içindeki en son hareketleri izleyin. Hisse senedi fiyat tablosunu aşağıda bulabilirsiniz. ... TME Pharma NV için hisse senedi sembolü "ALTME".
- TME Pharma is considering several solid tumors for further clinical development. Further information can be found at: www.tmepharma.com.
- TME Pharma is headquartered in Berlin, Germany. How many employees does TME Pharma have? ... TME Pharma is a life science company.
TME Pharma
Биотехнологическая компания
Краткая информация
Факты
- Дата основания:1997 год
- Количество сотрудников:10 (2017 г.)
- Сайт: